Vijaya Diagnostic Centre has allotted 1,70,384 equity shares under ESOP on 03 May 2024. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from Rs 10,23,45,693/- to Rs 10,25,16,077/-.Powered by Capital Market - Live News

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 8 May 2024.Powered by Capital Market - Live News

Net profit of Vijaya Diagnostic Centre rose 58.01% to Rs 25.85 crore in the quarter ended December 2023 as against Rs 16.36 crore during the previous quarter ended December 2022. Sales rose 17.30% to Rs 132.69 crore in the quarter ended December 2023 as against Rs 113.12 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales132.69113.12 17 OPM %39.4239.14 - PBDT51.3542.30 21 PBT36.8122.02 67 NP25.8516.36 58 Powered by Capital Market - Live News

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 5 February 2024.Powered by Capital Market - Live News

The Board of Directors of Vijaya Diagnostic Centre at their meeting held today have inter-alia considered and approved the terms and conditions of the Share Purchase agreement (SPA) between the Company, P H Diagnostic Centre (P H / Target) and its Promoters/Shareholders (Sellers) or the acquisition of 100% stake in �P H�. Post completion of the aforesaid acquisition, �P H� will become wholly-owned subsidiary(WOS) of the Company. The cost of acquisition is Rs 134.65 crore. Additionally, Rs 12.85 crore shall be infused into the Target Company by way of either equity or loan to pay the existing debt. Powered by Capital Market - Live News